课题基金 / 基金详情

Regulation of inhibitory synapse function by Neuroligin 2 membrane dynamics, trafficking and phosphorylation

Regulation of inhibitory synapse function by Neuroligin 2 membrane dynamics, trafficking and phosphorylation
Neuroligin 2 膜动力学、运输和磷酸化对抑制性突触功能的调节
批准号:
BB/S017496/1
负责人:
Josef Kittler
金额:
$70.12万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

Josef Kittler的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Nerve cells communicate with each other via specialised cell-cell contact sites called synapses. On the presynaptic side the input neuron releases neurotransmitters that activate specialised neurotransmitter receptors located on the receiving neuron at the postsynaptic side. Synapses can have either an excitatory (activating) or an inhibitory (inactivating) role in brain signalling. For the brain to function well, it is important that synapses are formed correctly, i.e. the pre- and postsynaptic side are precisely apposed to each other, and that brain activity is properly regulated. If synapses do not wire correctly during development or go wrong later in life this can lead to devastating neuropsychiatric and neurodegenerative brain disorders like Schizophrenia, autism and Alzheimer's disease, respectively. The protein family of Neuroligins play a key role in synapse formation and maintenance. They are positioned in the membrane of the postsynaptic side and, by binding the protein Neurexin at the presynaptic side, bridge the synaptic cleft. Neuroligin-2 (NL2) is specifically located at the inhibitory synapse, where it induces clustering of the protein gephyrin to form a scaffold. The main inhibitory neurotransmitter receptor of our central nervous system, the GABA-A receptor, is then stabilised at the synapse by gephyrin and LHFPL4. Synapses can change their strength in response to changes in neural activity, an important property for key brain functions such as learning and memory, and for maintaining the balance between excitation and inhibition. The strength of the response at a synapse can be regulated by altering the size of the scaffold and the number of attached neurotransmitter receptors. Through its role in stabilising the synapse, NL2 is likely to be a key regulator of the number of GABA-A receptors in the postsynaptic membrane, and thus of inhibitory synapse strength and information processing in the brain. Little is known, however, about the molecular mechanisms that control NL2 number at the synapse, or its dynamic movement into and out of the synapse.We have initial data suggesting that brain activity causes a change in the amount of NL2 on the cell surface, through its release from the synapse and uptake into the cell (a process called endocytosis). We have also identified a number of novel proteins that interact with NL2 and may be involved with either its stabilisation at the synapse, or regulating whether NL2 taken into the cell is recycled to the synapse or sent for destruction. It is, however, still unknown how brain activity affects these processes, and reciprocally how alterations of NL2 number at the synapse affects its strength. Our research is therefore aimed at answering the following related questions:- Under what physiologically relevant conditions is the stability of NL2 at the synapse altered?- How do the various binding partners of NL2 regulate its stability at the synapse, as well as its endocytosis, recycling and degradation?- How do changes in the amount of NL2 at the synapse affect the strength of the inhibitory synapse?Ultimately, by gaining molecular insight into how inhibitory synapses are formed and regulated, we will better understand how wiring in the brain is controlled. In addition, since synaptic dysfunction is implicated in many neurodegenerative and neuropsychiatric diseases, our proposed work may also lead to an improved understanding of diseases such as epilepsy, stroke, Alzheimer's disease, Huntington's disease and schizophrenia, and may suggest targets for therapeutic intervention. A detailed understanding of the processes that we study for NL2, will also have implications for other Neuroligins, synaptic membrane proteins, and membrane proteins in non-neuronal cells. Thus, our research may contribute to understanding basic cell biological principles as well as specifically how connections in the brain are formed and maintained.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
PKA-mediated phosphorylation of Neuroligin-2 regulates its cell surface expression and synaptic stabilisation
PKA 介导的 Neuroligin-2 磷酸化调节其细胞表面表达和突触稳定
DOI: 10.1101/2020.07.23.218008
发表时间: 2020
期刊:
影响因子: --
作者: [Halff E]
通讯作者: Halff E
Physics-based Deep Learning for Imaging Neuronal Activity via Two-photon and Light Field Microscopy
基于物理的深度学习通过双光子和光场显微镜对神经元活动进行成像
DOI: 10.1101/2022.10.11.511633
发表时间: 2022
期刊:
影响因子: --
作者: [Verinaz-Jadan H]
通讯作者: Verinaz-Jadan H
DOI: 10.1093/brain/awac272
发表时间: 2023-02-13
期刊: Brain : a journal of neurology
影响因子: --
作者: []
通讯作者:
Phosphorylation of neuroligin-2 by PKA regulates its cell surface abundance and synaptic stabilization.
PKA 磷酸化 Neuroligin-2 可调节其细胞表面丰度和突触稳定性。
DOI: 10.1126/scisignal.abg2505
发表时间: 2022
期刊: Science signaling
影响因子: 7.3
作者: [Halff EF]
通讯作者: Halff EF
Multimodal Video Search by Examples (MVSE)
  • 批准号:
    EP/V002856/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $110.04万
  • 财政年份:
    2021
  • 负责人:
    Josef Kittler
  • 依托单位:
(N00014-16-R-FO05) Semantic Information Pursuit for Multimodal Data Analysis
  • 批准号:
    EP/R018456/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $124.98万
  • 财政年份:
    2018
  • 负责人:
    Josef Kittler
  • 依托单位:
Synaptic and circuit pathology in a mouse model of AP4 deficiency syndrome
  • 批准号:
    MR/N025644/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $68.3万
  • 财政年份:
    2016
  • 负责人:
    Josef Kittler
  • 依托单位:
Face Matching for Automatic Identity Retrieval, Recognition, Verification and Management
  • 批准号:
    EP/N007743/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $777.81万
  • 财政年份:
    2016
  • 负责人:
    Josef Kittler
  • 依托单位:
国内基金
海外基金
Crocin 抑制 Hartley 豚鼠早期骨关节炎发生的 作用机制研究
空气颗粒物通过调控白血病抑制因子参与影响IgA肾病进展的作用与机制研究
  • 批准号:
    82370711
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    谢静远
  • 依托单位:
利用人源性抗-MIF噬菌体抗体防治大肠癌肝转移的研究
  • 批准号:
    30470435
  • 项目类别:
    面上项目
  • 资助金额:
    8.0万元
  • 批准年份:
    2004
  • 负责人:
    何兴祥
  • 依托单位: